Literature DB >> 10206290

Cytotoxic drugs efficacy correlates with adipose tissue docosahexaenoic acid level in locally advanced breast carcinoma.

P Bougnoux1, E Germain, V Chajès, B Hubert, C Lhuillery, O Le Floch, G Body, G Calais.   

Abstract

Experimental studies indicated that long-chain polyunsaturated fatty acids may increase sensitivity of mammary tumours to several cytotoxic drugs. To evaluate this hypothesis in breast cancer, we have prospectively studied the association between levels of fatty acids stored in breast adipose tissue and the response of the tumour to chemotherapy in 56 patients with an initially localized breast carcinoma. Adipose breast tissue was obtained at the time of biopsy, and individual fatty acids were measured as a percentage of total fatty acids using capillary gas chromatography. Patients then received primary chemotherapy, combining mitoxantrone, vindesine, cyclophosphamide and 5-fluorouracil every 4 weeks. Tumour size was reassessed after three cycles of chemotherapy. Tumour response was evaluated according to World Health Organization criteria. Complete or partial response to chemotherapy was achieved in 26 patients (47%). Level of n-3 polyunsaturated fatty acids in adipose tissue was higher in the group of patients with complete or partial response to chemotherapy than in patients with no response or with tumour progression (P < 0.004). Among n-3 polyunsaturated, only docosahexaenoic acid (22:6n-3) was significantly associated with tumour response (P < 0.005). In a logistic regression analysis taking into account age, body mass index and tumour size, 22:6 n-3 level proved to be an independent predictor for chemosensitivity (P = 0.03). These results suggest that, in breast cancer, 22:6 n-3 may increase the response of the tumour to the cytotoxic agents used.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206290      PMCID: PMC2362790          DOI: 10.1038/sj.bjc.6690281

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Intervention of transplantable human mammary carcinoma MX-1 chemotherapy with dietary menhaden oil in athymic mice: increased therapeutic effects and decreased toxicity of cyclophosphamide.

Authors:  Y Shao; L Pardini; R S Pardini
Journal:  Nutr Cancer       Date:  1997       Impact factor: 2.900

2.  Membrane fatty acids of breast carcinoma: contribution of host fatty acids and tumor properties.

Authors:  V Chajès; M Lanson; F Fetissof; C Lhuillery; P Bougnoux
Journal:  Int J Cancer       Date:  1995-10-09       Impact factor: 7.396

3.  Increased accumulation of drugs in a multidrug resistant cell line by alteration of membrane biophysical properties.

Authors:  R Callaghan; A Stafford; R M Epand
Journal:  Biochim Biophys Acta       Date:  1993-02-17

4.  Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm.

Authors:  G Calais; C Berger; P Descamps; S Chapet; A Reynaud-Bougnoux; G Body; P Bougnoux; J Lansac; O Le Floch
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

5.  Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E.

Authors:  V Chajès; W Sattler; A Stranzl; G M Kostner
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

6.  Treatment failure and dietary habits in women with breast cancer.

Authors:  L E Holm; E Nordevang; M L Hjalmar; E Lidbrink; E Callmer; B Nilsson
Journal:  J Natl Cancer Inst       Date:  1993-01-06       Impact factor: 13.506

7.  Dietary menhaden oil enhances mitomycin C antitumor activity toward human mammary carcinoma MX-1.

Authors:  Y Shao; L Pardini; R S Pardini
Journal:  Lipids       Date:  1995-11       Impact factor: 1.880

8.  Enhancement of the antineoplastic effect of mitomycin C by dietary fat.

Authors:  Y Shao; L Pardini; R S Pardini
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

9.  Effects of iron supplementation and ET-18-OCH3 on MDA-MB 231 breast carcinomas in nude mice consuming a fish oil diet.

Authors:  W E Hardman; C J Barnes; C W Knight; I L Cameron
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  alpha-Linolenic acid content of adipose breast tissue: a host determinant of the risk of early metastasis in breast cancer.

Authors:  P Bougnoux; S Koscielny; V Chajès; P Descamps; C Couet; G Calais
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

View more
  10 in total

1.  Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER(-) breast cancer cells.

Authors:  Julia B Ewaschuk; Marnie Newell; Catherine J Field
Journal:  Lipids       Date:  2012-10-07       Impact factor: 1.880

Review 2.  Role of dietary fatty acids in mammary gland development and breast cancer.

Authors:  Mira MacLennan; David W L Ma
Journal:  Breast Cancer Res       Date:  2010-10-26       Impact factor: 6.466

Review 3.  ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy.

Authors:  Paola Antonia Corsetto; Irma Colombo; Joanna Kopecka; Angela Maria Rizzo; Chiara Riganti
Journal:  Int J Mol Sci       Date:  2017-12-20       Impact factor: 5.923

4.  Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on DHA Levels and Omega-3 Index in Red Blood Cell Membranes of Breast Cancer Patients.

Authors:  Alessio Molfino; Maria I Amabile; Sara Mazzucco; Gianni Biolo; Alessio Farcomeni; Cesarina Ramaccini; Simonetta Antonaroli; Massimo Monti; Maurizio Muscaritoli
Journal:  Front Physiol       Date:  2017-07-28       Impact factor: 4.566

5.  Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trial.

Authors:  Marnie Newell; John R Mackey; Gilbert Bigras; Mirey Alvarez-Camacho; Susan Goruk; Sunita Ghosh; Alison Schmidt; Deborah Miede; Ann Chisotti; Lynne Postovit; Kristi Baker; Vera Mazurak; Kerry Courneya; Richard Berendt; Wei-Feng Dong; George Wood; Sanraj K Basi; Anil Abraham Joy; Karen King; Judith Meza-Junco; Xiaofu Zhu; Catherine Field
Journal:  BMJ Open       Date:  2019-09-17       Impact factor: 2.692

6.  Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.

Authors:  Alois Kozubík; Alena Vaculová; Karel Soucek; Jan Vondrácek; Jaroslav Turánek; Jirina Hofmanová
Journal:  Met Based Drugs       Date:  2008

7.  Clinical Response of Metastatic Breast Cancer to Multi-targeted Therapeutic Approach: A Single Case Report.

Authors:  Christian Meiners
Journal:  Cancers (Basel)       Date:  2011-03-17       Impact factor: 6.639

Review 8.  Diet components can suppress inflammation and reduce cancer risk.

Authors:  W Elaine Hardman
Journal:  Nutr Res Pract       Date:  2014-05-15       Impact factor: 1.926

9.  First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma.

Authors:  Alberto Bongiovanni; Nada Riva; Marianna Ricci; Chiara Liverani; Federico La Manna; Alessandro De Vita; Flavia Foca; Laura Mercatali; Stefano Severi; Dino Amadori; Toni Ibrahim
Journal:  Onco Targets Ther       Date:  2015-12-03       Impact factor: 4.147

Review 10.  The Mediterranean Diet and Breast Cancer: A Personalised Approach.

Authors:  Amani Al Shaikh; Andrea J Braakhuis; Karen S Bishop
Journal:  Healthcare (Basel)       Date:  2019-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.